Notice of Effectiveness (effect)
14 Aprile 2023 - 12:07PM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | April 13,
2023 |
---|
Form: | S-3 |
---|
CIK: | 0001880438 |
---|
Company Name: | AN2 Therapeutics, Inc. |
---|
File Number: | 333-271174 |
---|
Grafico Azioni AN2 Therapeutics (NASDAQ:ANTX)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni AN2 Therapeutics (NASDAQ:ANTX)
Storico
Da Mag 2023 a Mag 2024